Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance.

BACKGROUND Despite evidence supporting short antibiotic prophylaxis (ABP), it is still common practice to continue ABP for more than 48 hours after coronary artery bypass graft (CABG) surgery. METHODS AND RESULTS To compare the effect of short (<48 hours) versus prolonged (>48 hours) ABP on surgical site infections (SSIs) and acquired antimicrobial resistance, we conducted an observational 4-year cohort study at a tertiary-care center. An experienced infection control nurse performed prospective surveillance of 2641 patients undergoing CABG surgery. The main exposure was the duration of ABP, and main outcomes were the adjusted rate of SSI and the isolation of cephalosporin-resistant enterobacteriaceae and vancomycin-resistant enterococci (acquired antibiotic resistance). Adjustment for confounding was performed by multivariable modeling. A total of 231 SSIs (8.7%) occurred after a median of 16 days, including 93 chest-wound infections (3.5%) and 13 deep-organ-space infections (0. 5%). After 1502 procedures using short ABP, 131 SSIs were recorded, compared with 100 SSIs after 1139 operations with prolonged ABP (crude OR, 1.0; CI, 0.8 to 1.3). After adjustment for possible confounding, prolonged ABP was not associated with a decreased risk of SSI (adjusted OR, 1.2; CI, 0.8 to 1.6) and was correlated with an increased risk of acquired antibiotic resistance (adjusted OR, 1.6; CI, 1.1 to 2.6). CONCLUSIONS Our findings confirm that continuing ABP beyond 48 hours after CABG surgery is still widespread; however, this practice is ineffective in reducing SSI, increases antimicrobial resistance, and should therefore be avoided.

[1]  D. Kreisel,et al.  Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. , 1995, Archives of surgery.

[2]  D. Maki,et al.  Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. , 1992, The Journal of thoracic and cardiovascular surgery.

[3]  R. Wenzel,et al.  Nosocomial urinary tract infections cause wound infections postoperatively in surgical patients. , 1983, Surgery, gynecology & obstetrics.

[4]  H. Boxma,et al.  Randomised controlled trial of single-dose antibiotic prophylaxis in surgical treatment of closed fractures: the Dutch Trauma Trial , 1996, The Lancet.

[5]  J. Salomone,et al.  Cost and morbidity associated with antibiotic prophylaxis in the ICU. , 1999, Journal of the American College of Surgeons.

[6]  D. Goldmann,et al.  Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens. , 1977, The Journal of thoracic and cardiovascular surgery.

[7]  R. Jones,et al.  Mediastinitis After Coronary Artery Bypass Graft Surgery: Risk Factors and Long‐Term Survival , 1995, Circulation.

[8]  G. Archer,et al.  Alteration of staphylococcal flora in cardiac surgery patients receiving antibiotic prophylaxis. , 1983, The Journal of infectious diseases.

[9]  C. Martin,et al.  Quality of perioperative antibiotic administration by French anaesthetists. , 1998, The Journal of hospital infection.

[10]  M. Turina,et al.  Cardiac surgery in a high-risk group of patients: is prolonged postoperative antibiotic prophylaxis effective? , 1997, The Journal of thoracic and cardiovascular surgery.

[11]  R. Leggiadro,et al.  Prophylactic antibiotic use in pediatric cardiovascular surgery: a survey of current practice. , 1995, The Pediatric infectious disease journal.

[12]  D. Kernodle,et al.  Low-level colonization of hospitalized patients with methicillin-resistant coagulase-negative staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis , 1988, Antimicrobial Agents and Chemotherapy.

[13]  M. Finland,et al.  Changing ecology of bacterial infections as related to antibacterial therapy. , 1970, The Journal of infectious diseases.

[14]  J. Degener,et al.  Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis. , 1999, The Journal of hospital infection.

[15]  Matthew H. Samore,et al.  A clinical data repository enhances hospital infection control , 1997, AMIA.

[16]  R L Menlove,et al.  The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. , 1992, The New England journal of medicine.

[17]  M. Raebel,et al.  Antimicrobial Prophylaxis in Coronary Bypass Surgery: A Critical Appraisal , 1991, DICP : the annals of pharmacotherapy.

[18]  N. J. Ehrenkranz,et al.  Antimicrobial Prophylaxis in Surgery: Mechanisms, Misconceptions, and Mischief , 1993, Infection Control &#x0026; Hospital Epidemiology.

[19]  F. Shabbo,et al.  Antibiotic prophylaxis for cardiac surgery: current United Kingdom practice. , 1993, British heart journal.

[20]  D. Demetriades,et al.  Antibiotic prophylaxis in penetrating injuries of the chest. , 1991, Annals of the Royal College of Surgeons of England.

[21]  A. Michalopoulos,et al.  Antibiotic prophylaxis in cardiac surgery. , 1997, The Journal of cardiovascular surgery.

[22]  B. Kreter,et al.  Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials. , 1992, The Journal of thoracic and cardiovascular surgery.

[23]  M. McDonald,et al.  Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. , 1998, The Australian and New Zealand journal of surgery.

[24]  R. M. Nelson,et al.  The economic implications of infection in cardiac surgery. , 1986, The Annals of thoracic surgery.

[25]  W J Martone,et al.  CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. , 1992, American journal of infection control.

[26]  W. Ghali,et al.  Hospital cost of complications associated with coronary artery bypass graft surgery. , 1997, The American journal of cardiology.